Opharmic Technology key facts
- Manufacturer of ultrasound-mediated technologies intended and devices designed to provide non-invasive ocular drug delivery for a variety of eye diseases and conditions.
- Notable investors include MassChallenge, MedTech Innovator, Hong Kong Science & Technology Parks, Shanghai Healthcare Capital, HKSTP Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Opharmic Technology: the Monday email on marks, rounds and moves
Opharmic Technology funding rounds
No funding rounds for Opharmic Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Opharmic Technology investors
8 investors are on record for Opharmic Technology, including MassChallenge, MedTech Innovator, Hong Kong Science & Technology Parks and Shanghai Healthcare Capital.
About Opharmic Technology
Manufacturer of ultrasound-mediated technologies intended and devices designed to provide non-invasive ocular drug delivery for a variety of eye diseases and conditions. The company's ultrasound technology is been precisely engineered to stimulate cellular transport activities and to modulate the barrier properties of the eye tissue or enhance drug uptake, enabling clients to replace needle injections and efficiently deliver drugs into the eye using the low-energy ultrasonic technology.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2016
- Employees
- 4
- Website
- opharmic.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Opharmic Technology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.